annual CFI:
-$205.60M-$180.41M(-716.36%)Summary
- As of today (September 14, 2025), MLTX annual cash flow from investing activities is -$205.60 million, with the most recent change of -$180.41 million (-716.36%) on December 31, 2024.
- During the last 3 years, MLTX annual CFI has fallen by -$205.54 million (-405413.41%).
- MLTX annual CFI is now -405413.41% below its all-time high of -$50.70 thousand, reached on December 31, 2021.
Performance
MLTX Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
$88.25M+$32.01M(+56.91%)Summary
- As of today (September 14, 2025), MLTX quarterly cash flow from investing activities is $88.25 million, with the most recent change of +$32.01 million (+56.91%) on June 30, 2025.
- Over the past year, MLTX quarterly CFI has increased by +$176.00 million (+200.58%).
- MLTX quarterly CFI is now -24.48% below its all-time high of $116.87 million, reached on December 31, 2023.
Performance
MLTX quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
$55.45M+$176.00M(+146.00%)Summary
- As of today (September 14, 2025), MLTX TTM cash flow from investing activities is $55.45 million, with the most recent change of +$176.00 million (+146.00%) on June 30, 2025.
- Over the past year, MLTX TTM CFI has increased by +$229.51 million (+131.86%).
- MLTX TTM CFI is now -5.38% below its all-time high of $58.60 million, reached on September 30, 2024.
Performance
MLTX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
MLTX Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -716.4% | +200.6% | +131.9% |
| 3 y3 years | -10000.0% | +100.0% | +10000.0% |
| 5 y5 years | -78.8% | - | - |
MLTX Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | <-9999.0% | at low | -24.5% | +150.6% | -5.4% | +127.0% |
| 5 y | 5-year | <-9999.0% | at low | -24.5% | +150.6% | -5.4% | +127.0% |
| alltime | all time | <-9999.0% | at low | -24.5% | +150.6% | -5.4% | +127.0% |
MLTX Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $88.25M(+56.9%) | $55.45M(-146.0%) |
| Mar 2025 | - | $56.25M(-138.2%) | -$120.55M(-41.4%) |
| Dec 2024 | -$205.60M(+716.4%) | -$147.33M(-352.8%) | -$205.60M(-450.8%) |
| Sep 2024 | - | $58.28M(-166.4%) | $58.60M(-133.7%) |
| Jun 2024 | - | -$87.74M(+204.6%) | -$174.06M(+136.4%) |
| Mar 2024 | - | -$28.80M(-124.6%) | -$73.64M(+192.4%) |
| Dec 2023 | -$25.18M | $116.87M(-167.0%) | -$25.18M(-80.9%) |
| Sep 2023 | - | -$174.38M(-1475.6%) | -$132.15M(<-9900.0%) |
| Jun 2023 | - | $12.68M(-35.5%) | $0.00(-100.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | $19.65M(+98.4%) | -$12.68M(-60.8%) |
| Dec 2022 | -$32.34M(>+9900.0%) | $9.90M(-123.4%) | -$32.34M(-23.5%) |
| Sep 2022 | - | -$42.23M(<-9900.0%) | -$42.26M(>+9900.0%) |
| Jun 2022 | - | $0.00(-100.0%) | -$46.00K(-31.0%) |
| Mar 2022 | - | -$16.00K(-13.0%) | -$66.70K(+31.6%) |
| Dec 2021 | -$50.70K(-100.0%) | -$18.40K(+58.6%) | -$50.70K(-100.0%) |
| Sep 2021 | - | -$11.60K(-44.0%) | -$115.03M(+0.0%) |
| Jun 2021 | - | -$20.70K(<-9900.0%) | -$115.02M(+0.0%) |
| Mar 2021 | - | $0.00(-100.0%) | -$115.00M(0.0%) |
| Dec 2020 | -$115.00M | -$115.00M | -$115.00M |
FAQ
- What is MoonLake Immunotherapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual CFI year-on-year change?
- What is MoonLake Immunotherapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly CFI year-on-year change?
- What is MoonLake Immunotherapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics TTM CFI year-on-year change?
What is MoonLake Immunotherapeutics annual cash flow from investing activities?
The current annual CFI of MLTX is -$205.60M
What is the all time high annual CFI for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual cash flow from investing activities is -$50.70K
What is MoonLake Immunotherapeutics annual CFI year-on-year change?
Over the past year, MLTX annual cash flow from investing activities has changed by -$180.41M (-716.36%)
What is MoonLake Immunotherapeutics quarterly cash flow from investing activities?
The current quarterly CFI of MLTX is $88.25M
What is the all time high quarterly CFI for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly cash flow from investing activities is $116.87M
What is MoonLake Immunotherapeutics quarterly CFI year-on-year change?
Over the past year, MLTX quarterly cash flow from investing activities has changed by +$176.00M (+200.58%)
What is MoonLake Immunotherapeutics TTM cash flow from investing activities?
The current TTM CFI of MLTX is $55.45M
What is the all time high TTM CFI for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high TTM cash flow from investing activities is $58.60M
What is MoonLake Immunotherapeutics TTM CFI year-on-year change?
Over the past year, MLTX TTM cash flow from investing activities has changed by +$229.51M (+131.86%)